Atai Life Sciences N.V. (ATAI)
1.42
0.09 (6.77%)
At close: Jan 15, 2025, 9:46 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -40.22M | -157.42M | -174.24M | -178.63M | -24.38M |
| Depreciation & Amortization | 319.00K | 168.00K | 47.00K | 24.00K | 6.00K |
| Stock-Based Compensation | 32.98M | 42.38M | 63.36M | 67.16M | 57.00K |
| Other Working Capital | 5.33M | -301.00K | -9.90M | 2.75M | -375.00K |
| Other Non-Cash Items | -84.66M | 8.67M | 16.06M | 29.88M | 9.06M |
| Deferred Income Tax | n/a | 5.07M | 39.13M | 56.35M | 7.54M |
| Change in Working Capital | 7.47M | -3.33M | -7.60M | 4.45M | -126.00K |
| Operating Cash Flow | -84.12M | -104.47M | -63.25M | -20.77M | -7.85M |
| Capital Expenditures | -590.00K | -1.02M | -1.13M | -59.00K | -19.00K |
| Acquisitions | -443.00K | n/a | -52.94M | -2.09M | -456.00K |
| Purchase of Investments | -185.26M | -309.66M | -23.66M | -23.92M | -11.55M |
| Sales Maturities Of Investments | 139.47M | 226.83M | -955.00K | n/a | 10.31M |
| Other Investing Acitivies | -6.47M | -3.00M | -2.60M | -2.20M | -7.32M |
| Investing Cash Flow | -53.30M | -86.85M | -81.28M | -28.27M | -9.03M |
| Debt Repayment | n/a | 15.00M | 1.59M | 32.50M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -8.36M | 5.79M | -1.61M | -1.89M | -2.29M |
| Financial Cash Flow | -8.36M | 20.79M | 409.86M | 113.05M | 40.39M |
| Net Cash Flow | -145.58M | -171.65M | 265.02M | 67.18M | 23.14M |
| Free Cash Flow | -84.71M | -105.49M | -64.37M | -20.82M | -7.87M |